Filing Details

Accession Number:
0001214659-25-007221
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-05-08 20:51:50
Reporting Period:
2025-05-06
Filing Date:
2025-05-08
Accepted Time:
2025-05-08 20:51:50
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1635088 Roivant Sciences Ltd. ROIV () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1635075 Vivek Ramaswamy C/O Steve Roberts
853 New Jersey Ave., Suite 200-231
Washington DC 200003
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Disposition 2025-05-06 273,959 $11.47 39,799,611 No 4 S Direct
Common Shares Disposition 2025-05-07 625,000 $11.18 39,174,611 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Shares 13,357,857 Indirect Spousal
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.45 to $11.52, inclusive. The reporting person undertakes to provide to Roivant Sciences Ltd., any security holder of Roivant Sciences Ltd., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.10 to $11.26, inclusive.
  3. Represents the quantity of shares held indirectly only.